Metastatic dormancy imposed by the primary tumor: Does it exist in humans?

Annals of Surgical Oncology

Volumn 15, Issue 11, 2008, Pages 3308-3315

  Peeters, Charlotte F J M ^a   De Waal, Robert M W ^a   Wobbes, Theo ^a   Ruers, Theo J M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Angiogenesis; Colorectal cancer; Liver metastases

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER SURGERY; COLORECTAL CANCER; HUMAN; HUMAN TISSUE; METABOLISM; METASTASIS; MITOSIS RATE; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; TUMOR VASCULARIZATION;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; PROGNOSIS; TUMOR BURDEN;

EID: 55149088567     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0029-5     Document Type: Article

References (74)

1. Sugarbaker E, Thornthwaite J, Ketcham A. Inhibitory effect of a primary tumor on metastasis. In: Day SB, Myers WPL, Stansly P, Garattini S, Lewis MG (eds) Progress in Cancer Research and Therapy. New York: Raven 1977; 227-40.
2. L Simpson-Herren AH Sanford JP Holmquist 1976 Effects of surgery on the cell kinetics of residual tumor Cancer Treat Rep 60 1749 60
3. B Fisher N Gunduz EA Saffer 1983 Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases Cancer Res 43 1488 92
4. P Carmeliet RK Jain 2000 Angiogenesis in cancer and other diseases Nature 407 249 57
5. SG Ronan AM Eng HA Briele 1987 Thin malignant melanomas with regression and metastases Arch Dermatol 123 1326 30
6. V Schirrmacher 1985 Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies Adv Cancer Res 43 1 73
7. AJ Saldbury JA McKinna JD Griffiths 1965 Circulating cancer cells during excision of carcinomas of the rectum and colon with high ligation of the inferior mesenteric vein Surg Gynecol Obstet 120 1266 70
8. RC Golinger RM Gregorio ER Fisher 1977 Tumor cells in venous blood draining mammary carcinomas Arch Surg 112 707 8
9. RB Turnbull Jr 1975 Current concepts in cancer. Cancer of the GI tract: colon, rectum, anus. The no-touch isolation technique of resection JAMA 231 1181 2
10. B Fisher EA Saffer ER Fisher 1970 Comparison of concomitant and sinecomitant tumor immunity Proc Soc Exp Biol Med 135 68 71
11. RD Bonfil RA Ruggiero OD Bustuoabad 1988 Role of concomitant resistance in the development of murine lung metastases Int J Cancer 41 415 22
12. IJ Fidler 1990 Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture Cancer Res 50 6130 8
13. MS O'Reilly L Holmgren Y Shing 1994 Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 315 28
14. MS O'Reilly L Holmgren C Chen 1996 Angiostatin induces and sustains dormancy of human primary tumors in mice Nat Med 2 689 92
15. J Folkman 1992 The role of angiogenesis in tumor growth Semin Cancer Biol 3 65 71
16. IJ Fidler LM Ellis 1994 The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 79 185 8
17. LM Ellis IJ Fidler 1996 Angiogenesis, metastasis Eur J Cancer 32A 2451 60
18. D Hanahan J Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353 64
19. LA Liotta PS Steeg WG Stetler-Stevenson 1991 Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation Cell 64 327 36
20. MS O'Reilly T Boehm Y Shing 1997 Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 277 85
21. K Camphausen MA Moses WD Beecken 2001 Radiation therapy to a primary tumor accelerates metastatic growth in mice Cancer Res 61 2207 11
22. A Sckell N Safabakhsh M Dellian 1998 Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice Cancer Res 58 5866 9
23. TS Li Y Kaneda K Ueda 2001 The influence of tumour resection on angiostatin levels and tumour growth-an experimental study in tumour-bearing mice Eur J Cancer 37 2283 8
24. M Guba G Cernaianu G Koehl 2001 A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis Cancer Res 61 5575 9
25. PH Lange K Hekmat G Bosl 1980 Acclerated growth of testicular cancer after cytoreductive surgery Cancer 45 1498 506
26. MM Elhilali M Gleave Y Fradet 2000 Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology Group BJU Int 86 613 8
27. JM Yuhas NH Pazmino 1974 Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread Cancer Res 34 2005 10
28. H Igarashi M Esumi H Ishida 2002 Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma Cancer 95 47 53
29. J Holash PC Maisonpierre D Compton 1999 Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 284 1994 8
30. WP Leenders B Kusters RM de Waal 2002 Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis Endothelium 9 83 7
31. AL Feldman HR Alexander Jr DL Bartlett 2001 A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases Ann Surg Oncol 8 741 5
32. CF Peeters JR Westphal RM de Waal 2004 Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients Int J Cancer 112 554 9
33. CF Peeters RM de Waal T Wobbes 2006 Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation Int J Cancer 15 1249 53
34. CF Peeters RM de Waal T Wobbes 2006 Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation Int J Cancer 119 1249 53
35. CF Peeters LF de Geus JR Westphal 2005 Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases Surgery 137 246 9
36. WG Stetler-Stevenson 2008 The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2 Cancer Metastasis Rev 27 57 66
37. B Glimelius O Dahl B Cedermark 2005 Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group Acta Oncol 44 904 12
38. I Chau AR Norman D Cunningham 2005 A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer Ann Oncol 16 549 57
39. J Folkman 2002 Role of angiogenesis in tumor growth and metastasis Semin Oncol 29 15 8
40. Y Maeshima A Sudhakar JC Lively 2002 An endothelial cell-specific inhibitor of protein synthesis Science 295 140 3
41. G Siemeister M Schirner P Reusch 1998 An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells Proc Natl Acad Sci USA 95 4625 9
42. SS Yoon H Eto CM Lin 1999 Mouse endostatin inhibits the formation of lung and liver metastases Cancer Res 59 6251 6
43. CG Willett Y Boucher E Di Tomaso 2004 Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nat Med 10 145 7
44. D Cunningham Y Humblet S Siena 2004 Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337 45
45. CG Willett Y Boucher DG Duda 2005 Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients J Clin Oncol 23 8136 9
46. H Hurwitz L Fehrenbacher W Novotny 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 42
47. H Hurwitz F Kabbinavar 2005 Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer Oncology 69 17 24
48. EA te Velde EE Voest JM van Gorp 2002 Adverse effects of the antiangiogenic agent angiostatin on the healing of experimental colonic anastomoses Ann Surg Oncol 9 303 9
49. EA te Velde B Kusters C Maass 2003 Histological analysis of defective colonic healing as a result of angiostatin treatment Exp Mol Pathol 75 119 23
50. Gruenberger T. Tumor response to pre-operative chemotherapy (CT) with FOLFOX-4 for resectable colorectal cancer liver metastases (LM). Interim results of EORTC Intergroup randomized phase III study 40983. J Clin Oncol (abstr 3500) 24[18S]. 2006. Ref Type: Abstract
51. Nordlinger B. Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol (abstr LBA5) 25[18S]. 2007. Ref Type: Abstract
52. Gruenberger. Effectiveness of neoadjuvant chemotherapy including bevacizumab in patients with resectable colorectal cancer liver metastases. J Clin Oncol (abstr 4060B) 25[ 18S]. 2007. Ref Type: Abstract
53. Malavasi N. Phase II trial to evaluate combination of folfox6 + bevacizumab in initially unresectable liver metastases from colorectal cancer (crc). J Clin Oncol (abstr 14603) 25[18S]. 2007. Ref Type: Abstract
54. Lowery MA. Hypertensison is a significant adverse effect of bevacizumab treatment. J Clin Oncol (abstr 14134) 25[18S]. 2007. Ref Type: Abstract
55. Julie C. Pathological analysis of hepatic injury after oxaliplatin-based neoadjuvant chemotherapy of colorectal cancer liver metastases: results of the EORTC Intergroup phase III study 40983. Gastrointestinal Cancer Symposium, Orlando, Florida (abstr 241). 2007. Ref Type: Abstract
56. LM Ellis SA Curley A Grothey 2005 Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab J Clin Oncol 23 4853 5
57. SH Song KH Jung JY Paik 2005 Distribution and pharmacokinetic analysis of angiostatin radioiodine labeled with high stability Nucl Med Biol 32 845 50
58. D Hanahan G Bergers E Bergsland 2000 Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice J Clin Invest 105 1045 7
59. G Gasparini 2001 Metronomic scheduling: the future of chemotherapy? Lancet Oncol 2 733 40
60. R Munoz Y Shaked F Bertolini 2005 Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy Breast 14 466 79
61. D Cunningham WH Allum SP Stenning 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20
62. Cunningham D, Allum WH, Stenning SP, et al, for the NCRI Upper GI Cancer Clinical Studies Groups. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: final results of a randomized controlles trial (the MAGIC trial, ISRCTN 93793971). Proc Am Soc Clin Oncol 23[308s]. 2005. Ref Type: Abstract
63. D Mauri N Pavlidis JP Ioannidis 2005 Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis J Natl Cancer Inst 97 188 94
64. G Bonadonna P Valagussa C Brambilla 1998 Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute J Clin Oncol 16 93 100
65. JA van der Hage CJ Van de Velde JP Julien 2001 Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 4224 37
66. R Sauer H Becker W Hohenberger 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731 40
67. JF Bosset L Collette G Calais 2006 Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114 23
68. JP Gerard T Conroy F Bonnetain 2006 Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 4620 5
69. JF Bosset G Calais L Mineur 2005 Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921 J Clin Oncol 23 5620 7
70. NA Janjan VS Khoo J Abbruzzese 1999 Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M Int J Radiat Oncol Biol Phys 44 1027 38
71. RS Chari DS Tyler MS Anscher 1995 Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum Ann Surg 221 778 86
72. ET Chen M Mohiuddin H Brodovsky 1994 Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation Int J Radiat Oncol Biol Phys 30 169 75
73. H Isomoto M Tomita K Sugimachi 2003 Pre- and postoperative adjuvant chemotherapy in colorectal cancer Int J Oncol 23 1103 8
74. T Matsuura Y Fukuda T Fujitaka 2000 Preoperative treatment with tegafur suppositories enhances apoptosis and reduces the intratumoral microvessel density of human colorectal carcinoma Cancer 88 1007 15